ESSA Pharma Stock Forecast

EPIX's stock price has decreased by -66.84% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 2 analysts with 12-month price forecasts for ESSA Pharma stock have an average target of 9.50, with a low estimate of 2.00 and a high estimate of 17. The average target predicts an increase of 429.25% from the current stock price of 1.80.

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$2.00	$9.50	$17	$17
Change	+11.42%	+429.25%	+847.08%	+847.08%

Analyst Ratings

The average analyst rating for ESSA Pharma stock from 4 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Jun '24	Jul '24	Aug '24	Sep '24	Oct '24	Nov '24
Strong Buy	0	0	0	0	0	0
Buy	2	2	2	2	2	1
Hold	0	0	0	0	0	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joseph Catanzaro Piper Sandler	Piper Sandler	Buy → Hold Downgrades $15 → $2	Buy → Hold	Downgrades	$15 → $2	+11.42%	Nov 4, 2024
Leland Gershell Oppenheimer	Oppenheimer	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Nov 4, 2024
Soumit Roy Jones Trading	Jones Trading	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Nov 1, 2024
Leland Gershell Oppenheimer	Oppenheimer	Buy Maintains $17	Buy	Maintains	$17	+847.08%	May 16, 2024
Mark Breidenbach Oppenheimer	Oppenheimer	Buy Reiterates $17	Buy	Reiterates	$17	+847.08%	Dec 13, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-0.69

from -0.60

EPS Next Year

-0.51

from -0.69

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Sep 30, 2019	Sep 30, 2020	Sep 30, 2021	Sep 30, 2022	Sep 30, 2023	Sep 30, 2024	Sep 30, 2025	Sep 30, 2026
Revenue	-	-	-	-	-	-	-	5.68M
Revenue Growth	-	-	-	-	-	-	-	-
EPS	-1.51	-1.04	-0.96	-0.80	-0.60	-0.69	-0.51	-0.40
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	7	7	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026
High	n/a	n/a	23.4M
Avg	n/a	n/a	5.7M
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2024	2025	2026
High	-0.63	-0.33	0.17
Avg	-0.69	-0.51	-0.40
Low	-0.74	-0.65	-0.76

EPS Growth

EPS Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.